Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Jan;65(759):51–52. doi: 10.1136/pgmj.65.759.51

Thrombophlebitis migrans following co-trimoxazole therapy.

J Verne-Pignatelli 1, G P Spickett 1, A G Dalgleish 1, A M Denman 1
PMCID: PMC2429135  PMID: 2789377

Abstract

We report an unusual and severe vasculitic disorder following co-trimoxazole, given orally for a urinary tract infection. The vasculitis was manifest solely as thrombophlebitis migrans and involving only veins without evidence of polyarteritis nodosa, or underlying malignancy.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis. 1982 Mar-Apr;4(2):426–428. doi: 10.1093/clinids/4.2.426. [DOI] [PubMed] [Google Scholar]
  2. Lawson D. H., Paice B. J. Adverse reactions to trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):429–433. doi: 10.1093/clinids/4.2.429. [DOI] [PubMed] [Google Scholar]
  3. doi: 10.1177/003591576205500107. [DOI] [PMC free article] [Google Scholar]
  4. Wãhlin A., Rosman N. Skin manifestations with vasculitis due to co-trimoxazole. Lancet. 1976 Dec 25;2(8000):1415–1415. doi: 10.1016/s0140-6736(76)91960-7. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES